21555501

Source:http://linkedlifedata.com/resource/pubmed/id/21555501

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008059, umls-concept:C0009014, umls-concept:C0087111, umls-concept:C0205653, umls-concept:C0304403, umls-concept:C0991507, umls-concept:C1263846
pubmed:issue	6
pubmed:dateCreated	2011-6-2
pubmed:abstractText	To assess the efficacy and safety of clonidine hydrochloride extended-release tablets (CLON-XR) combined with stimulants (ie, methylphenidate or amphetamine) for attention-deficit/hyperactivity disorder (ADHD).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0376422
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-2 Receptor Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Amphetamine, http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Stimulants, http://linkedlifedata.com/resource/pubmed/chemical/Clonidine, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Methylphenidate
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1098-4275
pubmed:author	pubmed-author:BramsMatthewM, pubmed-author:FindlingRobert LRL, pubmed-author:JainRakeshR, pubmed-author:KhayrallahMoiseM, pubmed-author:KollinsScott HSH, pubmed-author:SegalScottS, pubmed-author:WigalSharon BSB
pubmed:issnType	Electronic
pubmed:volume	127
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	e1406-13
pubmed:meshHeading	pubmed-meshheading:21555501-Adolescent, pubmed-meshheading:21555501-Adolescent Behavior, pubmed-meshheading:21555501-Adrenergic alpha-2 Receptor Agonists, pubmed-meshheading:21555501-Amphetamine, pubmed-meshheading:21555501-Attention Deficit Disorder with Hyperactivity, pubmed-meshheading:21555501-Central Nervous System Stimulants, pubmed-meshheading:21555501-Child, pubmed-meshheading:21555501-Child Behavior, pubmed-meshheading:21555501-Clonidine, pubmed-meshheading:21555501-Delayed-Action Preparations, pubmed-meshheading:21555501-Dose-Response Relationship, Drug, pubmed-meshheading:21555501-Double-Blind Method, pubmed-meshheading:21555501-Drug Therapy, Combination, pubmed-meshheading:21555501-Female, pubmed-meshheading:21555501-Follow-Up Studies, pubmed-meshheading:21555501-Humans, pubmed-meshheading:21555501-Male, pubmed-meshheading:21555501-Methylphenidate, pubmed-meshheading:21555501-Retrospective Studies, pubmed-meshheading:21555501-Treatment Outcome
pubmed:year	2011
pubmed:articleTitle	Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
pubmed:affiliation	Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, USA. kolli001@mc.duke.edu
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III, Research Support, N.I.H., Extramural